Daily Dose of Aniracetam: 750mg twice a day
Aniracetam is a fat soluble nootropic of the racetam family that can be effective at improving cognitive function. Compared to piracetam, it is more potent and requires a lower dosage. Like other nootropics in the racetam family, it is known for improving mitochondrial function and oxygen in the brain. It was first designed as a treatment for patients with dementia and is now also used with Alzheimer’s patients, showing great results. It is also beneficial for people who suffer from insomnia and even stroke patients.
Aniracetam is used as a cognitive enhancer and it works by stimulating memory and learning. As a nootropic, it enhances focus, vocabulary and even mood. It increases the release of dopamine and seratonin, which are chemicals that transmit nerve signals to the brain. These chemicals are known to make an individual happy and lift their mood. Cognitive ability is also controlled by chemicals, which are called neurotransmitters. Aniracetam is effective as a cognitive enhancer because it contains acetylcholine ,which is responsible for learning and memory. A lack of acetylcholine is in fact strongly linked to Alzheimer’s. Taking aniracetam can replace acetylcholine within the brain and is thought to help prevent this disease.
If you are thinking about taking aniracetam it is important to know that it is fat soluble and it is highly recommended to be taken with foods containing lipids, like fish oil or coconut oil. The recommended dosage is 750mg taken twice a day with meals or snacks. It is important to take the correct dosage when using Aniracetam. There is a chance when taking it with other Nootropics that you will experience nausea and even headaches. Remember before taking any supplement, make sure you talk to your doctor about it. It is prescribed mostly in European countries and is not sold over the counter worldwide.
- Ito I, Tanabe S, Kohda A, Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol. 1990 May;424:533-43. PMID: 1975272.
- Knapp RJ, Goldenberg R, Shuck C, Cecil A, Watkins J, Miller C, Crites G, Malatynska E. Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model. Eur J Pharmacol. 2002 Apr 5;440(1):27-35. PMID: 11959085.
- Lee CR, Benfield P. Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders. Drugs Aging. 1994 Mar;4(3):257-73. PMID: 8199398.